mirvetuximab
ImmunoGen
['mirvetuximab', 'ovarian']
recurent ovarian cancer . issuse and curent standard of care . mirvetuximab sorvtansine will be new drug for this difficultto treat disease #asco23 
Oncology care , to give or not to give chemo , data analysis , oncology pharamocovigilance , enthusiastic critic, twitts are not twists